IP Library Granted Patent US 9,404,161
Granted Patent B2
US 9,404,161 · App. 13/935,668 · Granted Aug 2, 2016

Method of detecting and quantifying coccidioides species

Inventors: David Engelthaler (Flagstaff, AZ); Elizabeth Driebe (Flagstaff, AZ); Paul Keim (Flagstaff, AZ); James M. Schupp (Flagstaff, AZ); Erin Kelley (Flagstaff, AZ)
Assignee: Translational Genomics Research Institute
C12Q1/6895C12Q2600/112
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,404,161
App. No.
13/935,668
Granted
Aug 2, 2016
Kind
B2
Abstract

The present invention provides methods and kits that may be used to detect and quantify the presence of Coccidioides species. The methods include quantification real-time PCR assays, and the kits and compositions include oligonucleotides used as primers and probes.

Claims (35)

1. A method of determining the presence or absence of Coccidioides in a DNA-containing sample comprising the steps of:

adding a first and a second oligonucleotide capable of binding SEQ ID NO. 1 to a mixture comprising the DNA-containing sample, wherein the first oligonucleotide includes at least one sequence selected from the group consisting of SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5 and oligonucleotides having at least 90% sequence identity to any one of SEQ ID NOs: 3-5, wherein the second oligonucleotide includes at least one sequence selected from the group consisting of SEQ ID NO. 6, SEQ ID NO. 7, SEQ ID NO. 8, SEQ ID NO. 9, and oligonucleotides having at least 90% sequence identity to any one of SEQ ID NOs: 6-9;

subjecting the mixture containing the first and second oligonucleotides to conditions that allow amplification of nucleic acid comprising the first oligonucleotide;

obtaining a result indicating nucleic acid amplification comprising the first oligonucleotide; and

determining the presence or absence of Coccidioides in the DNA-containing sample based on the result.

2. The method of claim 1 , wherein the result comprises a Ct value.

3. The method of claim 1 , wherein the first oligonucleotide is capable of hybridizing with complements of SEQ ID NO. 3, and the second oligonucleotide is capable of hybridizing with complements of SEQ ID NO. 6 in the mixture.

4. The method of claim 1 , further comprising the step of adding a third oligonucleotide to the mixture, wherein the third oligonucleotide binds to its complement included in the amplification products by the first and second oligonucleotides.

5. The method of claim 4 , wherein the third oligonucleotide includes a sequence selected from the group consisting of SEQ ID NO. 2 and oligonucleotides having at least 90% sequence identity to SEQ ID NO. 2.

6. The method of claim 4 , wherein at least one of the first, the second and the third oligonucleotides comprises a label.

7. The method of claim 6 , wherein the label comprises a fluorescent label.

8. The methods of claim 6 , wherein the third oligonucleotide comprises a fluorescent label.

9. The method of claim 1 , further comprising the step of isolating DNA from the DNA-containing sample.

10. The method of claim 1 , wherein the sample comprises an environmental sample.

11. The method of claim 1 , wherein the sample comprises a biological sample.

12. The method of claim 1 , wherein the sample is derived from a subject.

13. The method of claim 12 , wherein the subject is selected from the group consisting of a human, a companion animal, a domesticated animal, a livestock animal, and a wild animal species.

14. A method of quantifying Coccidioides in a DNA-containing sample comprising the steps of:

adding a first and a second oligonucleotides capable of binding SEQ ID NO. 1 to a mixture comprising the DNA-containing sample, wherein the first oligonucleotide includes a sequence selected from the group consisting of SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5and oligonucleotides having at least 90% sequence identity to any one of SEQ ID NOs: 3-5, wherein the second oligonucleotide includes a sequence selected from the group consisting of SEQ ID NO. 6, SEQ ID NO. 7, SEQ ID NO. 8, SEQ ID NO. 9, and oligonucleotides having at least 90% sequence identity to any one of SEQ ID NOs: 6-9;

subjecting the mixture containing the first and second oligonucleotides to conditions that allow amplification of a template DNA comprising the first oligonucleotide;

obtaining a first result indicating amplification of the template DNA and Coccidioides quantification; and

calculating Coccidioides quantification based on the first result in comparison to a reference result, wherein Coccidioides quantification determines the amount of template DNA in the sample.

15. The method of claim 14 , wherein the reference result is obtained by amplification of a DNA-containing sample having a known quantity of Coccidioides .

16. The method of claim 14 , wherein the reference result is predetermined.

17. The method of claim 14 , wherein the first and the reference result each comprises a Ct value.

18. The method of claim 14 , wherein the first oligonucleotide is capable of hybridizing with complements of SEQ ID NO. 3, and the second oligonucleotide is capable of hybridizing with complements of SEQ ID NO. 6in the mixture.

19. The method of claim 14 , further comprising the step of adding a third oligonucleotide to the mixture, wherein the third oligonucleotide binds to its complement included in the amplification products by the first and second oligonucleotides.

20. The method of claim 19 , wherein the third oligonucleotide includes a sequence selected from the group consisting of SEQ ID NO. 2 and oligonucleotides having at least 90% sequence identity to SEQ ID NO. 2.

21. The method of claim 19 , wherein at least one of the first, the second, and the third oligonucleotides comprises a label.

22. The method of claim 21 , wherein the label comprises a fluorescent label.

23. The method of claim 21 , wherein the third oligonucleotide comprises a fluorescent label.

24. The method of claim 14 , further comprising the step of isolating DNA from the DNA-containing sample.

25. The method of claim 14 , wherein the sample comprises an environmental sample.

26. The method of claim 14 , wherein the sample is derived from a subject.

27. The method of claim 26 , wherein the subject is selected from the group consisting of a human, a companion animal, a domesticated animal, a livestock animal, and a wild animal species.

Assignments (3)
CONFIRMATORY LICENSE Recorded Nov 24, 2015
From: TRANSLATIONAL GENOMICS RESEARCH INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 037155/0211 →
CONFIRMATORY LICENSE Recorded Dec 23, 2013
From: TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031867/0866 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2013
From: ENGELTHALER, DAVID; DRIEBE, ELIZABETH; KEIM, PAUL
To: TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
Reel/Frame 031168/0200 →
Continuity (2)
Provisional Application 61668203 · Jul 5, 2012
Related Publication 20140011693A1 · Jan 9, 2014